Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

Clinical trial NCT04667572 · COMPLETED

Trial details

NCT number: NCT04667572
Sponsor: Cornea Associates of Texas
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Keratoconus Pellucid Marginal Corneal Degeneration Corneal Degeneration Corneal Ectasia

Start date: 2021-02-01
Primary completion: 2024-08-21
Enrollment: 249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.